Coloplast A/S
CSE:COLO B

Watchlist Manager
Coloplast A/S Logo
Coloplast A/S
CSE:COLO B
Watchlist
Price: 549 DKK -0.47% Market Closed
Market Cap: 123.5B DKK

Coloplast A/S
Stock-Based Compensation

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Coloplast A/S
Stock-Based Compensation Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
Coloplast A/S
CSE:COLO B
Stock-Based Compensation
kr79m
CAGR 3-Years
16%
CAGR 5-Years
15%
CAGR 10-Years
N/A
No Stocks Found

Coloplast A/S
Glance View

Coloplast A/S, headquartered in Humlebæk, Denmark, has a storied history that dates back to 1954 when a nurse, Elise Sørensen, identified a crucial need in the healthcare sector. Her sister had undergone ostomy surgery, and the lack of appropriate post-operative care products inspired Sørensen to design the world’s first adhesive ostomy bag. This innovation laid the groundwork for Coloplast's trajectory in the healthcare industry. Today, the company has expanded its focus to include ostomy care, continence care, wound and skin care, and interventional urology. With a commitment to improving patients' quality of life, Coloplast has become a leader in designing and manufacturing products that not only highlight practicality but also embody comfort and discretion. Coloplast generates revenue through a business model that emphasizes product innovation and direct engagement with healthcare providers and patients. The company invests significantly in research and development to improve and widen its product offerings continuously. It operates globally, distributing its products directly and via partnerships with hospitals, clinics, and healthcare professionals. By maintaining an attentive approach to user experience and incorporating customer feedback into its development processes, Coloplast ensures its portfolio aligns with the actual needs of its users. This user-centered strategy not only enhances customer loyalty but also fortifies the company’s market position, driving its financial success.

COLO B Intrinsic Value
712.19 DKK
Undervaluation 23%
Intrinsic Value
Price

See Also

What is Coloplast A/S's Stock-Based Compensation?
Stock-Based Compensation
79m DKK

Based on the financial report for Sep 30, 2025, Coloplast A/S's Stock-Based Compensation amounts to 79m DKK.

What is Coloplast A/S's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 5Y
15%

Over the last year, the Stock-Based Compensation growth was 18%. The average annual Stock-Based Compensation growth rates for Coloplast A/S have been 16% over the past three years , 15% over the past five years .

Back to Top